| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nasus Pharma Ltd. (NSRX) has 1 insider with recent SEC Form 4 filings, including 1 buy and 0 sells. NSRX is classified in the Drug Manufacturers - General industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 157.0K | $532.2K | +2.9K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Teleman Dan Benjamin | Chief Executive Officer | Buy | 2,900 | $3.76 | $10,904.00 | +1.9% |